INSIGHTS ON CONTRACT PHARMA MANUFACTURING
-
Idea To Clinic: Accelerate Your Manufacturing Timeline To FIH Studies
Translating novel drug discoveries into clinical trials remains a complex endeavor. Learn how a CDMO with cutting-edge technologies can facilitate a smooth path from discovery to FIH studies.
-
Accelerating The Development And Production Of High-Quality Bispecific Antibodies
bsAbs are revolutionizing medicine by targeting two disease mechanisms simultaneously. Learn how an innovative platform offers excellent pairing and significantly enhances productivity and quality.
-
Breaking Bad Manufacturing Habits: Attaining Sustainable API Production
Sustainability is a growing issue in the pharmaceutical industry. Review strategies for reducing your carbon footprint and learn how the right CDMO can help drive the sustainable manufacture of APIs.
-
KinetiSol™ Technology
For poorly soluble drugs, overcoming absorption hurdles can hinder development. KinetiSol™ Technology empowers researchers to overcome solubility limitations and accelerate drug development.
-
Kinetisol Technology: Broader. Faster. Greener.
Explore how a solvent-free alternative for the production of amorphous solid dispersions (ASDs) not only improves manufacturability but also reduces the carbon footprint of ASD manufacturing.
-
Things To Consider In Early Development For Late-Stage NCE Success - Part Three: Quality Systems
Leveraging robust quality systems can improve efficiency throughout the product development lifecycle and help companies avoid unnecessary knowledge and tech transfer, saving both time and cost.
-
Modified Release Formulations: Extending Drug Commercial Lifecycle
A CDMO with expertise in modified-release dosage forms can provide valuable assistance in formulation development, processing considerations, analytical challenges, and regulatory requirements.
-
Improving An Abandoned Cancer Medication Using Innovative ASD Technology
Review the case study and learn how KinetiSol Solid Dispersion lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.
-
Delivering Commercial Success: Large-Scale API Production Services
Watch to see how one company excels in overcoming the most challenging small molecule API synthesis obstacles to help propel your program to new heights, regardless of the batch size.
-
Accelerating Rare Disease Treatments From Concept To Cure
Access a thorough investigation that delves into the critical aspects of expediting curative therapies, with a focus on the strategic role that CDMOs can play in this transformative journey.